Archives: Agenda

• Changing how researchers select potential patients for better success rates
• How to improve drug efficacy and patient safety before it’s too late
• Back to square one: Differentiating with simpler, patient-centric protocols and optimised study design
• Avoiding disappointing results by implementing the right technology tools to advance your trial
• Lessons learned to mitigate trial failures

Moderator: Sumeet Ambarkhane, Chief Medical Officer, Pathios Therapeutics

• Improving the sense of security to reduce unnecessary suffering and distress for patients
• Understanding the different types of patients and their individual response behaviours
• Being hyper aware of cultural differences and biases to ensure sensitivity and effective outcomes for all
• Sharing best practice on effective strategies with case studies and examples to help reduce patient drop out rate

• An overview of CAR-T trial trends in Oncology
• How we can apply regulatory, design, logistical and operational lessons learned to the new wave of CAR-T trials in the rare disease space

• Challenges in securing initial funding/additional financing
• Expense associated with drug development
• Loss of new pharmaceutical technologies and cutting-edge compounds
• Impact on patients in need of options

• Focus on the challenges patients face in trials: Learn what the data reveals about barriers to oncology trial participation and the toll of patient dropout.
• Learn how technology (when done right) can make trials easier for oncology patients: Explore solutions like travel support, streamlined patient payments, and eCOA.
• Hear success stories: Find out how recent case studies of eClinical solutions improved the patient and site experience.
• See how a Platform approach creates a smoother experience for patients and sites: Get the latest on the Suvoda-Greenphire merger and its suite of eight unified solutions.